Professor Rudolf Jaenisch of MIT and his former postdoc/now assistant professor at The Weizmann Jacob Hanna have gotten into a very public, stem cell skirmish over conflicting papers. Hanna raised concerns over a Jaenisch lab paper and things have escalated from there. This mess is playing out before our eyes on PubMed (there was a comment from Hanna […]
Public stem cell skirmish erupts between Hanna & Jaenisch Read More »
There has been relatively limited response from clinics themselves to the Cell Stem Cell paper that Leigh Turner and I published recently on the scope of the stem cell clinic industry in the U.S. We found 570 stem cell clinics and there could easily be 50-100 more that escaped our search methods or that have
Some stem cell clinics respond with ‘not me, them’ Read More »
Need a fix of some stem cell good news? I do. It has been a bumpy 2016 so far for the stem cell field and many challenges have popped up. So today at lunch and needing at least a short break from grant writing, I went looking for stem cell good news including interesting studies, promising
List of 11 stem cell good news or interesting stories Read More »
It’s an exciting time to be a stem cell scientist and I feel fortunate to be doing research on stem cells today what with all the developments recently and real promise for clinical impact in coming decades. There’s also unfortunately a ton of hype out there including in academia, biotech, and the stem cell clinic
Stem cells on the 4th of July: plenty of fireworks lately Read More »
Our new paper in the journal Cell Stem Cell on the large stem cell clinic marketplace in the U.S. documented a wide range of different kinds of clinics, stem cells used, and conditions claimed to be treated, but here I want to focus on the fat stem cell clinics in this post. I’m going to try
For better or worse, I am in the unique position of being a stem cell scientist and also a former cancer patient. Looking on the bright side this gives me a unique perspective on things compared to many of my colleagues. I know there are thousands of people out there looking for more practical information
Patients guide to stem cell treatments for 2021 Read More »
Now that the ISSCR annual meeting is over, some overall stem cell trends are evident from the meeting in terms of the direction of the stem cell field. This was one of my favorite ISSCR meetings. Translation expectation and upbeat tone. The overall vibe at the meeting was a sense of excitement and optimism about the
5 big picture stem cell trends at ISSCR 2016 Read More »
Dr. John Dick gave a great talk yesterday on cancer stem cells here at ISSCR 2016. Below I summarize his talk and as always with these meeting blogs, the post is not polished and is more of a stream of the speaker’s main points. He started out broadly with a nice introduction to this area of
Thought provoking talk from John Dick at ISSCR 2016 on cancer stem cells Read More »
An elderly woman in Australia reportedly died shortly after receiving a fat stem cell transplant. Sheila Drysdale passed away hours after getting an adipose stem cell treatment a few days before Christmas in 2013. That death is now being investigated by the coroner there. Not only is this death in Sydney distressing in it of
Woman’s death after “no big deal” fat stem cell therapy: coroner investigating Read More »
Stem cell studies continue to make big news with a mixed bag of trends including for stem cell biotech, and some good stem cell news and others not so much. Mesoblast ($MESO) had its stock suspended for quite so time recently in anticipation of a big announcement. When that news came today it was discouraging in
Stem cell biotech bites: Mesoblast, BioTime, MS, FDA Warning, & More Read More »